ChemoTech receives an order for an IQWave™ D-EECT from Baypointe Hospital in the Philippines
Baypointe has today signed an order for an IQWave™ D-EECT-equipment. The total order value is EUR 40,000.Payment will be made through a payment plan which runs on 18 months. In addition to the hospital, six of its doctors are co-investors in the IQWave™. This is a business model that the hospital is using to increase the recruitment of patients for new investments, something that we at ChemoTech hope will increase the number of patients that will be offered our technology, says Mohan Frick, CEO at ChemoTech. The delivery is expected to take place at the end of March 2018. I am